Variant Bio launches AI-powered platform for drug discovery using genetic data
Jan 6 (Reuters) – Variant Bio, a private biotech firm, said on Tuesday it has launched a platform…
Databricks raises $4B at $134B valuation as its AI business heats up
The IPO window may have cracked open, but it seems some former startups have no intention of going…